Commentary on Heath et al

Affiliations

• ¹ 1 Division of Hematology Products, Office of Hematology and Oncology Products, Office of New Drugs (OND), Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD, USA.
• ² 2 Office of New Drugs (OND), Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD, USA.
• ³ 3 Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD, USA.